100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Kevin Conroy Appointed to Abbott Laboratories Board of Directors
Notice of Proposed Settlement of Consolidated Derivative Action, Final Settlement Hearing, and Right to Appear
Earnings Release
Other Events, Press Release
Annual Report to Security Holders
Abbott Laboratories Issues $20 Billion in Senior Notes
Abbott Laboratories Enters $20 Billion Senior Notes Pricing Agreement
Abbott Laboratories Amends Board Composition in By-Laws
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Specialized Disclosure Report
Submission Upload
Correspondence